Growth Investment Partners (GIP) Ghana Ltd, a platform backed by British International Investment (BII), has announced an investment in mPharma Ghana Ltd, reflecting the continued need to improve access to affordable medicines and primary healthcare across West Africa.
The investment comes at a time when many households in Ghana and neighboring countries are struggling with rising drug prices, shortages of essential medicines and limited access to qualified health professionals, particularly in low-income and peri-urban areas.
Healthcare Access Under Pressure
Public and private health facilities continue to face supply chain challenges that lead to inconsistent availability of medicines. Many patients rely on out-of-pocket payments, placing a significant financial burden on families, especially those managing chronic conditions. Health analysts note that these gaps can result in delayed treatment and widening health inequalities.
Focus of the Investment
GIP’s financial support will be directed toward expanding pharmacy-based primary healthcare networks in Ghana and in selected Francophone West African countries. The goal is to improve medicine availability and strengthen community-level access points where most people seek care.
GIP Chief Executive Jacob Kholi said the investment is aimed at improving access to essential health services in underserved communities, adding that stronger primary healthcare systems are important for regional resilience.
Growing Role of Private Health Providers
The partnership highlights a broader shift in West Africa where private health providers are playing a larger role in frontline healthcare delivery. However, the sector continues to face operational challenges including regulation, cost pressures and the need for reliable medicine supply chains.
mPharma works with independent pharmacy owners under a franchise and supply partnership model. While the model expands access points for consultations and medicines, it has also sparked discussion within the pharmacy sector about price setting, competition and the future of small independent operators.
Investor Perspective
British International Investment has been active in supporting health access across the continent. BII Country Director for Ghana, Kwabena Asante-Poku, said the investment is intended to strengthen health delivery at the community level where gaps in medicine access remain most visible.
Sector observers note that similar investments are likely as the region’s population grows and demand for affordable primary healthcare rises.
What Comes Next
The effectiveness of the investment will be judged on whether it improves the affordability and availability of medicines while strengthening frontline care. Health economists say transparency in pricing and measurable outcomes will be important in maintaining public trust.
As chronic health conditions increase and urban populations expand, access to reliable and affordable primary care will remain a key challenge. The latest investment reflects ongoing efforts to address these gaps and shape the future structure of community-based healthcare in the region.
